Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × obinutuzumab × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 23 Lymphoma, Non-Hodgkin 10 Lymphoma, Follicular 9 Lymphoma 7 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia, Hairy Cell 2 Leukemia 2 Burkitt Lymphoma 2 Neoplasm, Residual 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Leukemia, B-Cell 1 Heart Failure 1 Extensive Stage Small Cell Lung Cancer 1 Cytokine Release Syndrome 1

Interventions

Specimen Handling 47 Magnetic Resonance Spectroscopy 47 enzalutamide 43 Prednisone 36 apalutamide 32 Abiraterone Acetate 32 Androgen Antagonists 31 Leuprolide 26 darolutamide 25 Radiotherapy 23 Docetaxel 22 Radiosurgery 21 abiraterone 20 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 17 relugolix 16 Biopsy 16 Goserelin 15 cabazitaxel 14 X-Rays 14 Radiation 14 Pluvicto 14 luprolide acetate gel depot 12 Triptorelin Pamoate 12 prednylidene 11 deltacortene 11 bicalutamide 11 Glutamate Carboxypeptidase II 11 Carboplatin 11 gallium 68 PSMA-11 10 Gonadotropin-Releasing Hormone 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡